During the past decade, ChulaBhorn Hospital conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "ChulaBhorn Hospital" #1 sponsor was "Chulabhorn Cancer Center" with 2 trials, followed by "Hoffmann-La Roche" with 2 trials sponsored, "Amgen" with 1 trials sponsored, "BeiGene" with 1 trials sponsored and "Chulabhorn Hospital" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "ChulaBhorn Hospital" #1 collaborator was "National Cancer Centre, Singapore" with 1 trials as a collaborator, "National Medical Research Council (NMRC), Singapore" with 1 trials as a collaborator, "Singapore Clinical Research Institute" with 1 trials as a collaborator, "Sirtex Medical" with 1 trials as a collaborator and "University of Glasgow" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "ChulaBhorn Hospital" are "Adverse Effect of Radiation Therapy" (2 trials), "Breast Cancer" (2 trials), "Advanced Lung Cancer" (1 trials), "Breast Neoplasms" (1 trials) and "Carcinoma, Hepatocellular" (1 trials). Many other conditions were trialed in "ChulaBhorn Hospital" in a lesser frequency.

Most popular intervention types in "ChulaBhorn Hospital" are "Drug" (6 trials), "Other" (4 trials), "Biological" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Nivolumab" (2 trials), "Atezolizumab" (1 trials), "Bemarituzumab" (1 trials) and "Bevacizumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "ChulaBhorn Hospital" are 10 trials for "All" genders.

Currently, there are NaN active trials in "ChulaBhorn Hospital". undefined are not yet recruiting, 4 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in ChulaBhorn Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in ChulaBhorn Hospital, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".